台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-元大-敦化 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

元大-敦化 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/08567.5000.0067.3054911.02%
2025/04/30261.2000.0059.6024700.42%
2025/04/1800.001059.0059.30-10482-2.07%
2025/04/15160.2000.0060.1014900.20%
2025/04/11360.1000.0059.2034930.61%
2025/04/08355.5700.0055.4034860.62%
2025/03/3100.00368.0767.50-3561-0.53%
2025/03/27273.9500.0073.6025730.35%
2025/03/25274.3000.0076.0025940.34%
2025/03/2100.00872.2572.40-8594-1.35%
2025/03/1300.00279.4081.00-2603-0.33%
2025/03/1200.00377.5077.50-3585-0.51%
2025/03/11377.5700.0081.5035570.54%
2025/03/1000.00276.8076.80-2518-0.39%
2025/03/07269.65171.0069.9014960.20%
2025/03/0600.001268.8867.60-12483-2.48%
2025/03/051270.4600.0068.90124842.48%
2025/03/031064.6500.0069.60104832.07%
2025/02/2100.00172.2067.80-1508-0.20%
2025/02/20171.001064.6571.00-9497-1.81%
2025/02/191165.1700.0065.50114902.24%
2025/02/18162.2000.0062.6015020.20%
2025/02/17162.5000.0062.2015210.19%
2025/02/13463.3500.0062.8045740.70%
2025/02/1100.00261.8064.00-2594-0.34%
2025/02/10159.7000.0060.4015880.17%
2025/02/05261.2500.0060.7026050.33%
2025/02/0400.00161.0060.70-1605-0.17%
2025/01/2200.00160.2060.90-1604-0.17%
2025/01/1700.00358.9358.60-3616-0.49%
2025/01/15161.6000.0061.0016160.16%
2025/01/1300.00264.9562.80-2627-0.32%
2025/01/1000.00165.3065.40-1624-0.16%
2025/01/0800.001.562.2362.00-1.5618-0.24%
2025/01/06163.30164.6065.1006230.00%
2025/01/0200.00164.0064.20-1643-0.16%
2024/12/30167.60166.4066.7006920.00%
2024/12/27163.7000.0063.3016970.14%
2024/12/261068.572.569.8866.607.56921.08%
2024/12/25573.4000.0074.0056830.73%
2024/12/2400.00373.0073.00-3677-0.44%
2024/12/2300.00166.4066.40-1680-0.15%
2024/12/19963.6100.0062.7096951.29%
2024/12/1800.00160.8060.90-1678-0.15%
2024/12/17456.10155.5055.4036780.44%
2024/12/1300.00153.6054.90-1678-0.15%
2024/12/12154.80455.7854.90-3678-0.44%
2024/12/11354.9700.0054.9036660.45%
2024/12/10363.1700.0060.9036480.46%
2024/12/0900.00262.6062.00-2646-0.31%
2024/12/03167.8000.0067.8016620.15%
2024/11/29167.9000.0067.9016710.15%
2024/11/2800.00664.6064.80-6672-0.89%
2024/11/27267.7500.0066.5026770.30%
2024/11/26168.5000.0068.6016810.15%
2024/11/22372.77171.3073.0026720.30%
2024/11/2100.00568.2468.00-5662-0.76%
2024/11/201568.1300.0067.40156662.25%
2024/11/1800.00266.8567.00-2676-0.30%
2024/11/15165.7000.0066.0016780.15%
2024/11/14164.00165.9069.0006700.00%
2024/11/13464.8800.0064.0046520.61%
2024/11/12367.83363.3070.0006320.00%
2024/11/11770.10470.3070.1036060.49%
2024/11/082.179.891580.1377.80-13603-2.15%
2024/11/07486.4000.0086.1046200.64%
2024/11/0400.00291.0091.80-2637-0.31%
2024/10/28295.7500.0095.5026880.29%
2024/10/2500.003100.67100.00-3687-0.44%
2024/10/235107.0000.00104.0057100.70%
2024/10/221100.501101.50107.0007260.00%
2024/10/182113.0000.00110.0027680.26%
2024/10/171122.5000.00122.0017790.13%
2024/10/162119.0000.00117.0027990.25%
2024/10/140.2120.5000.00121.000.28170.02%
2024/10/091116.5000.00119.0018380.12%
2024/10/081128.001126.50126.0008390.00%
2024/10/076110.926116.92116.5008300.00%
2024/10/0400.001106.50106.50-1813-0.12%
2024/10/01397.7700.0097.2037870.38%
2024/09/304108.0000.00108.0047770.51%
2024/09/276121.831125.00120.0057960.63%
2024/09/264136.2500.00133.0047850.51%
2024/09/252158.0000.00147.5027840.26%
2024/09/232154.000.5160.50158.001.57940.19%
2024/09/1900.004.2173.60177.00-4.2785-0.53%
2024/09/130.1189.000.2189.50178.00-0.1779-0.01%
2024/09/121189.0000.00187.5017840.13%
2024/09/111188.000191.50185.0017920.12%
2024/09/1000.000.1194.00183.00-0.1812-0.01%
2024/09/062202.7500.00195.0028000.25%
2024/09/054206.631208.00206.0037970.38%
2024/09/040209.501214.00207.00-1802-0.12%
2024/09/031219.0000.00217.0017970.13%
2024/08/300220.002222.00216.00-2792-0.25%
2024/08/292209.5000.00221.0027950.25%
2024/08/2800.000219.00210.0007880.00%
2024/08/270221.000223.00220.0007850.00%
2024/08/2300.000224.00229.0007980.00%
2024/08/220.1224.500222.00221.5007980.01%
2024/08/210218.0000.00225.0008020.00%
2024/08/200215.0000.00216.0008060.00%
2024/08/1900.000197.00201.5008200.00%
2024/08/1600.004192.14200.50-4822-0.49%
2024/08/153192.1700.00191.5038270.36%
2024/08/142189.5000.00192.0028410.24%
2024/08/131191.002.2193.15189.00-1.2843-0.15%
2024/08/126201.751198.03198.0058350.60%
2024/08/091181.2210191.45203.50-9824-1.09%
2024/08/080186.5000.00187.0007940.00%
2024/08/070176.5200.00180.0007810.01%
2024/08/061173.501175.50171.0007770.00%
2024/08/051.3170.091177.50180.000.37680.03%
2024/08/022180.240.3177.97177.501.77490.23%
2024/08/0100.003167.00175.50-3732-0.41%
2024/07/311.3158.8100.00161.001.37270.18%
2024/07/294144.752139.75141.5027080.28%
2024/07/261150.0000.00148.0017000.14%
2024/07/230.1156.0000.00160.000.16850.01%
2024/07/221164.0000.00164.0016670.15%
2024/07/192185.505180.51182.00-3650-0.46%
2024/07/188192.631195.50196.5076111.15%
2024/07/171.1174.221180.56191.000.15890.01%
2024/07/160.1167.551168.03174.50-0.9566-0.17%
2024/07/152164.500160.50164.5025540.36%
2024/07/120159.9300.00162.0005440.00%
2024/07/112149.5000.00149.0025310.38%
2024/07/034126.250127.00124.5044740.84%
2024/07/010136.504136.38137.50-4435-0.92%
2024/06/2700.002117.50118.50-2393-0.51%
2024/06/25299.5000.00101.5023730.54%
2024/06/2100.000105.50106.0003680.00%
2024/06/1800.001106.00104.50-1364-0.27%
2024/06/1700.0011107.59108.00-11353-3.11%
2024/06/1100.000101.00101.5003240.00%
2024/05/310.593.8200.0091.800.53170.16%
2024/05/30192.5000.0090.9013200.31%
2024/05/2800.000.799.70100.00-0.7312-0.22%
2024/05/240.299.981102.50105.00-0.8298-0.27%
2024/05/236.499.5617100.47100.50-10.6286-3.70%
2024/05/21092.6000.0093.0002500.00%
2024/05/200.485.0000.0086.300.42380.16%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音